Celonis SE – Trademark Portfolio
Entity Type: 83
Celonis SE holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 17 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 16 trademarks are registered and 2 are pending. Notable registered marks include C, PI, EMS, CELONIS, and CELOSPHERE.
Theresienstraße 6
80333 München
Showing of trademarks Trademarks
Trademark Classifications
Celonis SE's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Celonis SE have?
Celonis SE has 20 U.S. trademarks filed with the USPTO. Of these, 16 registered, 2 pending, 2 abandoned.
What trademark classes does Celonis SE file in?
Celonis SE files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 9 (Computers & Electronics). Class 35 covers advertising; business management; business administration; office functions.
What are Celonis SE's most well-known trademarks?
Celonis SE's registered trademark portfolio includes well-known marks such as C, PI, EMS, CELONIS, and CELOSPHERE. These are among 16 currently registered trademarks in the portfolio.
What is Celonis SE's trademark registration success rate?
Celonis SE has a 89% trademark registration rate, with 16 out of 18 resolved applications resulting in successful registration. Currently, 2 applications are pending review.